Elecsys HE4 Chinese Reference Value Study

计划入组 2,351 人 · 首次发布于 2012 年 11 月 30 日

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC

计划入组 600 人 · 首次发布于 2023 年 8 月 2 日

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

计划入组 5,429 人 · 首次发布于 2024 年 12 月 16 日

PT217

CNM-PtAu7

CR1-targeted vaccines(Elusys Therapeutics)

Elusys Therapeutics, Inc.

United States

FDA Grants Breakthrough Device Designation to Roche's Elecsys pTau217 Assay for Alzheimer's Diagnosis

Roche to Present New Trontinemab Long-Term Data and PrevenTRON Phase III Trial Design at AAIC 2026

Roche and Lilly's Alzheimer's Blood Test Receives FDA Breakthrough Device Designation